Vitaeris   Report issue

For profit Phase 3
Founded: Vancouver BC Canada (2016)
Status: Acquired by CSL Behring (2020)

Organization Overview

First Clinical Trial
2018
NCT03444103
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Vitaeris INC